ctrl K

Price Alert

Enlivex Therapeutics Ltd. (ENLV)

NASDAQ: ENLV · Real-Time Price · USD

1.05

-0.20 (-16.00%)

At close: Aug 19, 2025, 3:59 PM

1.05

-0.47%

After-hours: Aug 19, 2025, 06:39 PM EDT

Enlivex Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	3.3M	813K	47.82M	11.2M
Short-Term Investments	20.2M	26.51M	299K	72.93M
Long-Term Investments	531K	308K	307K	3K
Other Long-Term Assets	10K	179K	105K	482K
Receivables	1.3M	n/a	n/a	1.09M
Inventory	n/a	n/a	1.18M	-12.2M
Other Current Assets	198K	5.11M	n/a	1.2M
Total Current Assets	25.99M	33.76M	52.33M	86.44M
Property-Plant & Equipment	1.15M	2.58M	14.9M	8.22M
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	1.69M	3.07M	15.31M	8.7M
Total Assets	27.69M	36.83M	67.64M	95.15M
Account Payables	811K	827K	1.95M	878K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a
Other Current Liabilities	1.55M	1.57M	n/a	n/a
Total Current Liabilities	3.8M	6.06M	6.61M	4.72M
Long-Term Debt	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	299K	686K	4.19M	5.39M
Total Liabilities	4.1M	6.75M	10.8M	10.11M
Total Debt	534K	1.03M	4.85M	617K
Common Stock	2.69M	2.14M	2.12M	2.11M
Retained Earnings	-127.11M	-112.09M	-83.03M	-51.97M
Comprehensive Income	1.1M	1.1M	1.1M	1.1M
Shareholders Equity	23.59M	30.08M	56.84M	85.04M
Total Investments	20.73M	26.82M	299K	72.93M